RxPONDER: Even More Women May Forgo Chemo for Breast Cancer RxPONDER: Even More Women May Forgo Chemo for Breast Cancer

The first results from RxPONDER provide insight – and controversy – regarding the need for chemotherapy by women with node-positive, low-risk HR+, HER2- breast cancer.Medscape Medical News
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology News Source Type: news